Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Sexual Medicine
|
February 2, 2021
Safety and Effectiveness of Dapoxetine On Demand in Chinese Men With Premature Ejaculation: Results of a Multicenter, Prospective, Open-Label Phase IV Study
Jing Peng, Lin Yang, Long Liu, et al.
Journal of Clinical Medicine
|
May 14, 2022
<i>FGFR</i> Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC)
Ari Raphael, Elizabeth Dudnik, Dov Hershkovitz, et al.
Liver Cancer
|
December 18, 2025
Clinical Feasibility of Circulating Tumor DNA in Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab
Sohyun Hwang, Dong Jun Shin, Beodeul Kang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 18, 2023
Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system
Ching-Yao Yang, Jin-Yuan Shih, Wei-Yu Liao, et al.
NPJ Precision Oncology
|
June 19, 2024
AI powered quantification of nuclear morphology in cancers enables prediction of genome instability and prognosis
John Abel, Suyog Jain, Deepta Rajan, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Sexual Medicine
|
February 2, 2021
Safety and Effectiveness of Dapoxetine On Demand in Chinese Men With Premature Ejaculation: Results of a Multicenter, Prospective, Open-Label Phase IV Study
Jing Peng, Lin Yang, Long Liu, et al.
Journal of Clinical Medicine
|
May 14, 2022
<i>FGFR</i> Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC)
Ari Raphael, Elizabeth Dudnik, Dov Hershkovitz, et al.
Liver Cancer
|
December 18, 2025
Clinical Feasibility of Circulating Tumor DNA in Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab
Sohyun Hwang, Dong Jun Shin, Beodeul Kang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 18, 2023
Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system
Ching-Yao Yang, Jin-Yuan Shih, Wei-Yu Liao, et al.
NPJ Precision Oncology
|
June 19, 2024
AI powered quantification of nuclear morphology in cancers enables prediction of genome instability and prognosis
John Abel, Suyog Jain, Deepta Rajan, et al.
Page
of 2